New Zealand shares rose as promising results from a Covid-19 vaccine trial spurred optimistic investors to take positions in riskier stocks. Kathmandu Holdings led the market higher.

The S&P/NZX 50 Index advanced 152.25 points, or

Advertisement
Advertisement